Just a moment...
Convert scanned orders, printed notices, PDFs and images into clean, searchable, editable text within seconds. Starting at 2 Credits/page
Try Now →Press 'Enter' to add multiple search terms. Rules for Better Search
Use comma for multiple locations.
---------------- For section wise search only -----------------
Accuracy Level ~ 90%
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
Don't have an account? Register Here
Press 'Enter' after typing page number.
Issues: Whether Boroline was classifiable as a cosmetic and toilet preparation under Tariff Item 14F or as a patent or proprietary medicine under Tariff Item 14E, and whether the amended Explanation II to Tariff Item 14F changed the legal position.
Analysis: The product had earlier been treated, on the basis of settlement and departmental recognition, as a patent and proprietary medicine. The later amendment introducing Explanation II to Tariff Item 14F did not alter the essential nature of the product or convert its character from a medicinal preparation into a cosmetic merely because it contained subsidiary antiseptic constituents or had some curative or prophylactic value. The classification had to be determined by the product's essential ingredients and character, and on that basis Boroline remained essentially a drug.
Conclusion: The classification under Tariff Item 14F was rejected and Boroline was held to remain classifiable as a patent or proprietary medicine under Tariff Item 14E, in favour of the assessee.
Final Conclusion: The writ petition succeeded and the impugned excise classification treating Boroline as a cosmetic failed.
Ratio Decidendi: An amendment to a tariff explanation does not change the classification of a product where its essential character remains medicinal rather than cosmetic.